Inversions in the human genome found to be more common than previously thought

NewsGuard 100/100 Score

Researchers at EMBL Heidelberg found that inversions in the human genome are more common than previously thought, which impacts our understanding of certain genetic diseases.

Our DNA acts like a blueprint for the cellular machinery that lets cells, organs, and whole organisms function. Mutations in the DNA can result in genetic diseases. Such genetic variation can include point mutations at a single site, as well as deletions, duplications, and inversions.

The term 'inversion' describes a piece of DNA flipping its orientation in the genome. Inversions are poorly understood because they are more difficult to analyze than other types of mutations. Scientists at EMBL Heidelberg, in collaboration with scientists at the University of Washington, USA, and Heinrich Heine University Düsseldorf, Germany, have now shown that inversions are one of the most common mutational processes in humans.

The researchers uncovered how inversions are formed and investigated in detail a set of 40 inversions that form recurrently in the genome, where the DNA sequence flips back and forth. These 'flip-flopping' inversions typically lie in regions linked to the development of certain human diseases called genomic disorders.

We found that inversions form at a much higher rate than previously thought. In humans, at least 0.6% of the genome repeatedly changes direction, making inversion one of the fastest mutational processes in humans. At these sites, the genome is not stable – the direction of the DNA code continues to switch back and forth."

Jan Korbel, EMBL Senior Scientist and Head of Data Science

Many important human genes lie within these unstable regions. For scientists, this means they must consider this flipping behavior of genomic regions when they study aspects such as long-distance gene regulation or epigenetics.

Inversions are also relevant for the development of human diseases, such as developmental delays in children or neuropsychiatric disorders in adults. "Despite their importance, these regions have been very difficult to study before because of their complexity. Showing that these inversions indeed flip-flop back and forth required a new set of computational methods," said Tobias Marschall, Director of the Institute of Medical Biometry and Bioinformatics and the Heinrich Heine University Düsseldorf. "We can now provide human geneticists with a new tool to understand the origin of disease in their patients."

Evan Eichler, group leader at the University of Washington, said: "We showed for the first time that inversions can be associated with rare genomic rearrangements found in pediatric autism, developmental delay and epilepsy. The question now is why? We hypothesize that certain configurations at the flanks of the inversions either predispose or protect individuals and their offspring from disease-associated rearrangements. This could have a practical application in the clinic, where it could be used to identify families at risk for developing these disorders."

Source:
Journal reference:

Porubsky, D., et al. (2022) Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders. Cell. doi.org/10.1016/j.cell.2022.04.017.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial